What is it about?
The review details the Leishmaniasis, this complex group of neglected diseases, with important clinical spectrum and large epidemiological diversity, and discusses urgent need for less toxic, more specific and effective drugs against these parasites.
Featured Image
Perspectives
This review differs from the others by bring about a historical aspect and evolution of leishmaniasis, showing that even being an old disease, it is necessary to invest in research and development of effective and safe drugs.
Dr Viviane de Oliveira Freitas Lione
UFRJ
Read the Original
This page is a summary of: Leishmaniasis: History, Evolution of Treatment and the Need for New Drugs, Current Biotechnology, March 2015, Bentham Science Publishers,
DOI: 10.2174/2211550104666150303231736.
You can read the full text:
Contributors
The following have contributed to this page
